Skip to Main Content

There is an appointed time for everything — including in biotech. There is a time to start a company, a time to wind it down, a time to go public, and a time to delist the stock.

For every hopeful biotech toiling for decades before finally realizing a profit, there are countless others that run out of money or bet on a product that never delivers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED
  • That’s what I love about managers and c-suite, not matter how much they fail, there will always be some sucker out there willing to value very much their failures and incompetence.
    I wish it was the same for pretty much everything else in life!

Comments are closed.